V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20142915 | 20169820 | 1.57 | 86.3 | null | 2021-10-09 | 2021-12-27 | ACTICCA-1 Trial | 02 | N | ATEZOLIZUMAB | 100097838 |
| 20143244 | 20169821 | 1.61 | 108.1 | Palliative (P) | 2019-02-09 | 2019-02-22 | Topotecan (oral) | 02 | null | FLUDARABINE | 100190619 |
| 20143370 | 20169822 | 1.8 | 83.7 | Neo-adjuvant (N) | 2016-12-07 | 2017-01-04 | EOF | 02 | N | IBRUTINIB | 100028118 |
| 20143492 | 20169823 | 1.79 | 52.8 | null | 2020-07-12 | 2020-07-12 | Temozolomide 200mg/m2 | N | null | TRASTUZUMAB + VINORELBINE | 100834785 |
| 20143702 | 20169824 | 1.56 | 46.35 | null | 2018-02-04 | 2018-02-10 | Pazopanib | 02 | null | BEVACIZUMAB + IRINOTECAN + OXALIPLATIN + MDG | 100482860 |
| 20143988 | 20169825 | 1.72 | 14.8 | Palliative (P) | 2019-10-04 | 2019-10-12 | DOCETAXEL + GEMCITABINE | 02 | N | CAPITAL TRIAL | 101187221 |
| 20144687 | 20169826 | 1.98 | 76 | null | null | 2017-07-13 | CARBOPLATIN + GEMCITABINE | null | null | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100262936 |
| 20144867 | 20169827 | 1.62 | 55.4 | Palliative (P) | 2019-04-22 | 2019-05-03 | Gemcitabine + Oxaliplatin | N | N | GEMCITABINE + OXALIPLATIN | 100413733 |
| 20146423 | 20169828 | null | 70.6 | Palliative (P) | 2019-04-08 | 2019-04-22 | Capecitabine+Trastuzumab 21dayMaint | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101120411 |
| 20147170 | 20169829 | 1.81 | 88.7 | 03 | 2020-04-22 | 2020-04-23 | GemCarbo Days 1+8 | 02 | Y | CISPLATIN + PEMETREXED | 101789225 |
| 20147403 | 20169830 | 0 | 79.3 | null | 2019-07-06 | 2019-07-07 | CAV | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100772465 |
| 20148182 | 20169832 | 1.8 | 0 | Palliative (P) | 2019-02-22 | 2019-03-21 | Rituximab | 02 | N | CARBOPLATIN + VINORELBINE | 101627462 |
| 20148558 | 20169834 | 1.53 | 87.9 | Palliative (P) | 2020-01-11 | 2020-01-14 | Rituximab | 02 | N | ST03 TRIAL | 101213518 |
| 20149286 | 20169835 | 1.84 | 97 | null | 2021-09-09 | 2022-02-09 | ETOPOSIDE | 2 | N | TEMOZOLOMIDE | 101393517 |
| 20149423 | 20169836 | 1.59 | 63.3 | Neo-adjuvant (N) | 2021-06-09 | 2021-07-19 | Trabectedin | null | Y | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101183253 |
| 20150859 | 20169837 | 1.84 | 77.5 | Curative (C) | 2020-10-16 | 2021-08-01 | Cyclophosphamide + Docetaxel | 02 | null | CHOP R | 101533733 |
| 20150915 | 20169838 | 1.57 | 107 | null | 2020-02-02 | 2020-02-16 | ISATUXIMAB + POMALIDOMIDE | 02 | N | ABVD | 101319846 |
| 20151823 | 20169839 | 1.56 | 82.1 | null | 2021-12-15 | 2021-12-18 | Ixazomib + Lenalidomide | 02 | null | ATEZOLIZUMAB | 100679599 |
| 20151919 | 20169840 | 1.72 | 74.7 | null | 2021-01-18 | 2021-02-02 | FOXTROT TRIAL | 02 | N | CHOP R | 100567508 |
| 20152027 | 20169841 | 1.57 | null | null | 2018-03-31 | 2018-05-12 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | Y | MITOMYCIN | 100420980 |
| 20152042 | 20169842 | 1.8 | 20.2 | Palliative (P) | 2018-01-19 | 2018-04-27 | CISPLATIN + VINORELBINE + RT | 02 | N | DARATUMUMAB | 100555245 |
| 20152086 | 20169843 | 1.49 | 67.65 | Palliative (P) | 2021-07-11 | 2021-07-11 | CISPLATIN + TEYSUNO | null | null | CNS ATRT VCA VINC/DACTINO/CYCLOPHOS | 100729830 |
| 20153102 | 20169844 | 1.51 | 91 | Palliative (P) | 2018-02-07 | 2018-03-15 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | BORTEZOMIB | 100467017 |
| 20153459 | 20169845 | 1.54 | 73.75 | Palliative (P) | 2020-08-06 | 2020-08-06 | EEF or EOF | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100691069 |
| 20153571 | 20169846 | 1.68 | 85.4 | Palliative (P) | 2022-02-13 | 2022-02-13 | CAPECITABINE + LOMUSTINE | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101299683 |
| 20153599 | 20169847 | 1.72 | 81.2 | Palliative (P) | 2016-08-08 | 2016-08-18 | null | N | N | CETUXIMAB + IRINOTECAN | 101454725 |
| 20154024 | 20169848 | 1.7 | null | Neo-adjuvant (N) | 2019-12-24 | 2020-01-31 | null | null | N | HYDROXYCARBAMIDE | 101388079 |
| 20154032 | 20169849 | 1.72 | 78.8 | null | 2022-02-10 | 2022-02-19 | Cetuximab + Irinotecan (Cycle 1) | 02 | N | EOF | 100813637 |
| 20154366 | 20169850 | 1.56 | 53.2 | Curative (C) | 2019-08-04 | 2019-08-04 | ESHAP R | 02 | N | HYDROXYCARBAMIDE | 101140001 |
| 20154448 | 20169851 | 1.61 | 70.2 | null | 2018-03-16 | 2018-03-20 | CARBOPLATIN + VINORELBINE | 02 | null | CAPECITABINE + STREPTOZOCIN | 100917844 |
| 20154494 | 20169852 | 1.77 | null | Palliative (P) | 2022-01-29 | 2022-02-17 | Atezolizumab | null | N | DOCETAXEL + TRASTUZUMAB | 100960279 |
| 20154786 | 20169853 | 1.82 | 65.2 | Palliative (P) | 2018-12-01 | 2019-01-13 | Hydroxycarbamide | N | N | BORTEZOMIB + DARATUMUMAB + THALIDOMIDE | 100122535 |
| 20155154 | 20169854 | 1.83 | 53.4 | null | 2019-01-18 | 2019-01-25 | ALL UKALL60+ TRIAL | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 100514947 |
| 20155704 | 20169857 | 1.52 | 68.5 | Adjuvant (A) | 2018-11-29 | 2018-12-07 | NAB PACLITAXEL | 02 | N | CAPECITABINE + STREPTOZOCIN | 101430895 |
| 20155759 | 20169858 | 1.81 | 68.3 | null | 2019-10-14 | 2020-01-07 | Bortezomib + Daratumumab | 02 | null | GEMCITABINE + RT | 101793421 |
| 20156052 | 20169860 | 1.8 | 81.9 | null | 2018-08-10 | 2018-08-20 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | CISPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN | 100769542 |
| 20157177 | 20169862 | 1.84 | 75 | null | 2021-09-14 | 2021-09-15 | CARBOPLATIN + FLUOROURACIL | 02 | null | CARBOPLATIN + VINORELBINE | 101243634 |
| 20157247 | 20169863 | 1.71 | 94.6 | Neo-adjuvant (N) | 2021-03-27 | 2021-05-10 | Carboplatin + Docetaxel | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101484743 |
| 20157596 | 20169864 | null | 87 | Adjuvant (A) | 2017-12-24 | 2018-01-08 | Gemcitabine + Oxaliplatin | 02 | N | GEMCITABINE + OXALIPLATIN | 100080821 |
| 20158038 | 20169865 | 1.72 | 53 | null | 2019-07-10 | 2019-07-17 | Doxorubicin + Steptozotocin | 01 | null | CISPLATIN + FU + TRASTUZUMAB | 101558055 |
| 20158965 | 20169866 | 1.75 | 60 | Curative (C) | 2018-08-23 | 2018-09-03 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | BENDAMUSTINE + CYTARABINE + RITUXIMAB | 101443493 |
| 20159169 | 20169868 | 1.75 | 76 | Curative (C) | null | 2018-05-15 | TEYSUNO | null | null | PACLITAXEL + RAMUCIRUMAB | 100933100 |
| 20159217 | 20169869 | 1.84 | 86.1 | null | 2022-02-11 | 2022-02-13 | Cisplatin +FU +Trastuzumab - Load | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100609557 |
| 20159318 | 20169870 | 1.52 | 62.9 | Palliative (P) | 2017-01-09 | 2017-01-09 | ECarboF | 02 | N | ERIBULIN | 101398261 |
| 20159362 | 20169871 | 1.65 | 58 | null | null | 2020-12-24 | ECarboX | null | null | VINORELBINE | 101603763 |
| 20159370 | 20169872 | 1.77 | null | null | 2021-01-09 | 2021-01-15 | FOCUS4 TRIAL | 02 | null | CISPLATIN + FU + TRASTUZUMAB | 101429125 |
| 20159617 | 20169873 | 1.71 | 81 | Palliative (P) | 2022-05-11 | 2022-05-16 | CAPECITABINE + IRINOTECAN + Panitumumab | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPATIN | 100459460 |
| 20159702 | 20169874 | 1.76 | null | null | 2018-05-30 | 2018-06-07 | FLUOROURACIL + PEGINTERFERON ALFA | 02 | Y | CISPLATIN + VINORELBINE | 100838496 |
| 20159997 | 20169875 | 1.65 | 47.2 | Curative (C) | 2021-08-15 | 2021-09-14 | AFATINIB | Y | N | OLAPARIB | 100350157 |
| 20160123 | 20169876 | 1.75 | 61.8 | null | 2019-02-11 | 2019-03-13 | null | null | N | BACILLUS CALMETTE-GUERIN | 100490191 |